Predictive Oncology Launches Innovative Specialty Media for Growing Ovarian Tumors in the Lab
February 05, 2020 08:30 ET
|
Predictive Oncology Inc.
New Formulations Will Speed Discovery of Biomarkers and Precision Therapies MINNEAPOLIS, Feb. 05, 2020 (GLOBE NEWSWIRE) -- TumorGenesis, Inc. a subsidiary of Predictive Oncology, Inc. (NASDAQ:...
Predictive Oncology Inc. Signs Letter of Intent to Acquire Quantitative Medicine (qtmed.com) and an AI Engine™ (CoRE™) that Facilitates Accelerated Drug Discovery and Development
January 24, 2020 12:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial...
Predictive Oncology Inc. Appoints Pam Prior to Board of Directors
January 06, 2020 09:00 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services...
Predictive Oncology Inc. Announces Extension Of Promissory Note Due December 31, 2019
December 17, 2019 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services...
Predictive Oncology Provides Updates on Commercialization of Its Cancer Quest 2020 Initiative
December 09, 2019 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services...
Predictive Oncology Confirms Indications of Interest for Skyline Medical Business
December 05, 2019 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized...
Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
November 25, 2019 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized...
Predictive Oncology Secures $15,000,000 Equity Line
November 20, 2019 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized...
Predictive Oncology Inc. Reports Q3 Results; Revenues Increase 58%
November 15, 2019 17:10 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc., (NASDAQ: POAI) (“Predictive Oncology” or “the Company”) an artificial intelligence (AI) and data-driven functional precision...
Predictive Oncology Reaches First Milestone in Building AI-driven Predictive Models of Ovarian Cancer
October 31, 2019 08:30 ET
|
Predictive Oncology Inc.
MINNEAPOLIS, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized...